関連する実験動画
Updated: Aug 9, 2026

06:52
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
Published on: April 30, 2019
3メチルインドールによる牛とヤギの肺腫と肺腫の誘導
まとめ
ルメン微生物は,L-トリプトファンから3メチリンドールを生成し,牛やヤギの肺疾患を摂取または注入すると引き起こします. この研究は,家畜における急性肺疾患の主要な原因を特定しています.
科学分野:
- 獣医医学 獣医医学は,獣医医学というものです.
- 微生物学 微生物学とは
- 毒理学 毒理学 毒理学
背景:
- 類の消化には,飼料成分の微生物による発酵が含まれます.
- トリプトファンは,飼料に含まれる必須アミノ酸です.
- 特定の微生物の代謝物は,家畜に有毒な影響を与える可能性があります.
研究 の 目的:
- L-トリプトファンが3メチルインドルに変換される過程における反性の微生物の役割を調査する.
- 3メチルインドールが反動物における肺疾患を誘発するかどうかを判断する.
- 牛とヤギの急性肺疾患の潜在的な原因を特定するために.
主な方法:
- L-トリプトファンとインドレアセチン酸を用いて, rumenの微生物のインビトロインキュベーション.
- 3メチルインドルを口服および静脈経由で牛やヤギに投与する.
- 投与後の動物の臨床および病理学的検査.
主要な成果:
- 乳液中の微生物がL-トリプトファンとインドレアセチウム酸を3メチルインドールに in vitroで変換することが確認されました.
- 3-メチルインドールを口服すると,牛とヤギの腸内肺腫と肺が誘発された.
- また,3メチルインドールの静脈注入は,牛の肺疾患を引き起こした.
結論:
- 3メチルインドール (Ruminal tryptophan fermentationの最終産物) は,牛やヤギにおける急性肺疾患の強力な誘発因子である.
- この代謝経路を理解することは,反動物における呼吸器疾患の診断と予防に不可欠です.
- この研究は,食事,反性の発酵,および動物の健康との関連を強調しています.
関連する概念動画
Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

